Arsenic trioxide in the treatment of haematological malignancies.

about

Gadd45 proteins as critical signal transducers linking NF-kappaB to MAPK cascades Metabolism, toxicity and anticancer activities of arsenic compounds.Arsenic metabolism and thioarsenicals.

P2860

Q28388105-D534ABCD-2974-41D5-B3AE-C21BD7801D22 Q33618916-0A98B1CC-6A09-4A7A-AC83-EBD174131643 Q37987437-AB4E9BFD-78C9-4BC2-8B2F-92365A9B3FD7

P2860

Arsenic trioxide in the treatment of haematological malignancies.

Item

http://www.wikidata.org/entity/Q35925650

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Arsenic trioxide in the treatment of haematological malignancies.

@ast

Arsenic trioxide in the treatment of haematological malignancies.

@en

type

Item

label

Arsenic trioxide in the treatment of haematological malignancies.

@ast

Arsenic trioxide in the treatment of haematological malignancies.

@en

prefLabel

Arsenic trioxide in the treatment of haematological malignancies.

@ast

Arsenic trioxide in the treatment of haematological malignancies.

@en

P1476

Arsenic trioxide in the treatment of haematological malignancies.

@en

P2093

Yok-Lam Kwong

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic arsenic poisoning

The "retinoic acid syndrome" in acute promyelocytic leukemia

Arsenic inhibition of telomerase transcription leads to genetic instability

Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation

Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia

Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia

Torsade de pointes and T-U wave alternans associated with arsenic poisoning.

Combined treatment with arsenic trioxide and all-trans-retinoic acid in patients with relapsed acute promyelocytic leukemia.

Arsenite transport by mammalian aquaglyceroporins AQP7 and AQP9.

How acute promyelocytic leukaemia revived arsenic.

P304

589-597

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14740338.3.6.589

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15500417

http://www.w3.org/2001/XMLSchema#string

Arsenic trioxide in the treatment of haematological malignancies.

about

P2860

P2860

Arsenic trioxide in the treatment of haematological malignancies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698